Company / Debt per Share
NeoGenomics Laboratories, Inc. Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$2.67
FY2025
5-year range
$2.67 / $4.29
FY2021-FY2025
Trend
-37.5%
vs FY2024
Sector context
#76 of 98
Health Care
What the data says
NeoGenomics Laboratories, Inc.'s debt per share of $2.67 is lower than 78% of companies in the Health Care sector (FY2025). Improved from $4.29 to $2.67 over the past 2 years.
Based on SEC 10-K filings.
2.67 in FY2025.
Improved from $4.29 to $2.67 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 22% in Health CareTop 22% of 98This company $2.67 Sector average $46.19
▼
-94.2% below sector average
Key checks
Key Insights
- In FY2025, debt per share decreased 37.5% year-over-year.
- Ranks #76 out of 98 companies in the Health Care sector.
- Peak debt per share was recorded in FY2023.
- Lowest debt per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.67 | -37.5% |
| FY2024 | $4.27 | -0.4% |
| FY2023 | $4.29 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $1.11 | -9.7% |
| FY2017 | $1.23 | -4.7% |
| FY2016 | $1.29 | +41.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026